Risk Management Plan: Expert Review of Applications for Marketing Authorisation in the EAEU Depending on the Type of Medicinal Product (Review) von Bukatina, T. M., Shubnikova, E. V.

Volltext

Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document von Bukatina, T. M., Shubnikova, E. V.

Volltext

Critical Overview of the Contents of Risk Management Plans for Medicines von Bukatina, T. M., Shubnikova, E. V.

Volltext

Drug Safety Monitoring—International Information von Shubnikova, E. V., Bukatina, T. M., Kutekhova, G. V.

Volltext

Safety of Antibacterial and Antiprotozoal Medicinal Products von Shubnikova, E. V., Bukatina, T. M., Druzhinina, A. A., Zhuravleva, E. O., Kutekhova, G. V., Velts, N. Yu

Volltext

Ivermectin: Evaluation of Efficacy and Safety in COVID-19 von Shubnikova, E. V., Susekova, N. A., Bukatina, T. M., Galenko, M. S., Druzhinina, A. A.

Volltext

Comparative Analysis of International Databases of Adverse Drug Reactions von Kazakov, A. S., Darmostukova, M. A., Bukatina, T. M., Velts, N. Yu, Alyautdin, R. N.

Volltext

Efficacies and Chemical Structures of Modern Drugs for Hepatitis C Virus Treatment von Kazakov, A. S., Lepakhin, V. K., Bukatina, T. M., Snegireva, I. I., Zatolochina, K. É.

Volltext

Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents von Shubnikova, E. V., Bukatina, T. M., Velts, N. Yu, Kaperko, D. A., Kutekhova, G. V.

Volltext

Nonsteroidal anti-inflammatory drugs: problems of safe use von N. Yu. Velts, E. O. Zhuravleva, T. M. Bukatina, G. V. Kutekhova

Volltext

In Vitro Method of Studying the Angiotensin Activity of Chemical Compounds von Spasov, A. A., Yakovlev, D. S., Bukatina, T. M., Brigadirova, A. A.

Volltext

MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS von A. S. Kazakov, M. A. Darmostukova, T. M. Bukatina, I. I. Snegireva, V. K. Lepakhin, K. E. Zatolochina

Volltext

Nanoscale Therapeutic System: Safety Assessment Features von Bovina, E. M., Romanov, B. K., Kazakov, A. S., Velts, N. Yu, Zhuravleva, E. O., Bukatina, T. M., Alyautdin, R. N., Merkulov, V. A.

Volltext

The Adverse Drug Reactions Registered During the Postmarketing Period von Shubnikova, E. V., Darmostukova, M. A., Bukatina, T. M., Kaperko, D. A., Velts, N. Y., Kazakov, A. S., Snegireva, I. I., Zhuravleva, E. O., Kutekhova, G. V.

Volltext

Nicotine dependence and neuropsychotic effects of varenicline von T. M. Bukatina, A. S. Kazakov, R. N. Alyautdin, T. V. Romanova, I. I. Snegireva

Volltext

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS von N. Yu. Velts, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, M. A. Darmostukova, Yu. V. Olefir, B. K. Romanov, S. V. Glagolev, V. A. Polivanov

Volltext

POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS von E. V. Shubnikova, T. M. Bukatina, D. A. Kaperko, N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, I. I. Snegireva, E. O. Zhuravleva, G. V. Kutekhova

Volltext

UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4 von T. V. Romanova, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, I. I. Snegireva, M. A. Darmostukova, D. A. Kaperko, N. Yu. Velts, A. S. Kazakov, E. V. Shubnikova, R. N. Alyautdin

Volltext

Antithrombotic Activity of a New P2Y1 Receptor Antagonist, Substance Sbt-119, on Experimental Models of Thromboses in Rats von Yakovlev, D. S., Spasov, A. A., Bukatina, T. M., Smirnov, A. V., Suzdalev, K. F.

Volltext

Safety of apremilast: risk of psychical disorders von T. M. Bukatina, N. Yu. Velts, M. A. Darmostukova, E. Yu. Pasternak, T. V. Romanova

Volltext